Magaly Perez-Nieves
Overview
Explore the profile of Magaly Perez-Nieves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gelsey F, Schapiro D, Kosa K, Vass C, Perez-Nieves M, Pierce A, et al.
Diabetes Ther
. 2024 Sep;
15(11):2367-2379.
PMID: 39347898
Introduction: Daily insulin administration can be burdensome for people with type 2 diabetes (PwT2D) and can impact treatment adherence. This study investigated preferences for once-weekly, long-acting basal insulin for treatment...
2.
Brett McQueen R, Perez-Nieves M, Alonso G, Fan L, Hankosky E, Shah V, et al.
Diabetes Res Clin Pract
. 2024 May;
212:111690.
PMID: 38697300
Aims: Continuous glucose monitoring (CGM) metrics can assist diabetes management. Consensus statements recommend > 70 % time in range (TIR) and ≤ 36 % glucose coefficient of variation (CV). However,...
3.
Peter M, Rioles N, Liu J, Chapman K, Wolf W, Nguyen H, et al.
BMJ Open Diabetes Res Care
. 2023 Jul;
11(4).
PMID: 37423638
Introduction: Fear of hypoglycemia (FoH) affects quality of life, emotional well-being, and diabetes management among people with type 1 diabetes (PwT1D). American Diabetes Association's (ADA) guidelines recommend assessing FoH in...
4.
Kelly C, Nguyen H, Luo W, Chapman K, Poon J, Perez-Nieves M, et al.
Diabetes Ther
. 2023 Jun;
14(8):1285-1298.
PMID: 37268778
Introduction: Severe hypoglycemic events are distressing. Although past studies have shown that young adulthood is a potentially distressing time, few studies have explored distress about severe hypoglycemia in this age...
5.
Schapiro D, Juneja R, Huang A, Meeks A, Liu D, Gelsey F, et al.
Diabetes Ther
. 2023 May;
14(7):1157-1174.
PMID: 37184630
Introduction: Basal insulin's position in the type 2 diabetes (T2D) treatment paradigm has undergone significant revisions since the advent of diabetes medications such as glucagon-like peptide 1 receptor agonists (GLP-1RAs)...
6.
Liu J, Poon J, Bispham J, Perez-Nieves M, Hughes A, Chapman K, et al.
J Patient Rep Outcomes
. 2023 May;
7(1):43.
PMID: 37160500
Background: Fear of Hypoglycemia (FoH) in people with diabetes has a significant impact on their quality of life, psychological well-being, and self-management of disease. There are a few questionnaires assessing...
7.
Okazaki K, Takahashi N, Shingaki T, Perez-Nieves M, Stuckey H
Prim Care Diabetes
. 2022 Mar;
16(3):411-416.
PMID: 35256314
Aims: We report the key factors that motivate reluctant Japanese people with type 2 diabetes (T2D) to initiate insulin treatment. Methods: Participants were asked questions pertaining to 2 primary areas...
8.
Polonsky W, Fisher L, Hessler D, Desai U, King S, Perez-Nieves M
J Diabetes Complications
. 2021 Dec;
36(1):108103.
PMID: 34916146
Aims: To develop an updated, more theoretically sound system for describing and assessing diabetes-related emotional distress (DD) in adults with type 2 diabetes (T2D). Methods: Items were developed from qualitative...
9.
Chen J, Williams P, Perez-Nieves M, Piras de Oliveira C, Spaepen E, Osumili B, et al.
Diabetes Ther
. 2021 Sep;
12(11):2939-2953.
PMID: 34542865
Introduction: The study was designed to assess patient satisfaction, preferences and injection habits for patients using insulin lispro 200 units/ml pen (IL200) compared to their previously used disposable 100 units/ml...
10.
Caballero A, Nordstrom B, Liao B, Fan L, Zhang N, Fraeman K, et al.
J Diabetes Complications
. 2021 Sep;
35(11):108011.
PMID: 34535360
Aim: To identify which individual-, physician-, and the healthcare system-related factors can predict individualized hemoglobin A1c (HbA1c) targets and the likelihood of reaching those targets after initial insulin therapy over...